ERBB2 and breast carcinoma: Inhibition of cathepsin S expression markedly reduces the likelihood of brain metastasis.218 Brain metastases from triple negative or basal-type breast cancers frequently disrupt the BBB, in contrast to those from HER2/neu-positive breast cancer, which are inclined to maintain the BBB’s integrity.